Jordan Amadio, M.D., M.B.A. is a practicing neurosurgeon, the Innovation Fellow of the Congress of Neurological Surgeons, and a founding partner of NeuroLaunch, a pioneering neuroscience venture accelerator.
Since the founding of NeuroLaunch in 2014, the organization has facilitated investments in 11 brain tech companies, the onboarding of over 150 mentors, and the worldwide growth of a neurotechnology startup community.
Dr. Amadio is a graduate of Princeton University, where he received an honors degree in Physics and was a Barry Goldwater Scholar. In 2004, he was simultaneously awarded the Kusaka Memorial Prize in Physics and the Taylor Prize in Physics. He earned his M.D. degree from Harvard Medical School, where he was a research fellow in neurogenetics and was selected to complete his training in the Health Sciences and Technology (HST) program co-administered by the Massachusetts Institute of Technology. He was also among the first cohort of physicians to graduate with a concurrent Master’s in Business Administration (with Distinction) from Harvard Business School. He completed his training in Neurosurgery at Emory University School of Medicine in Atlanta, where he served as Chief Resident in 2016-17.
Dr. Amadio’s professional experience includes leadership in the areas of neurosurgery, neuroethics, bioengineering innovation, and health entrepreneurship. His scientific publications include research on electrolyte disturbances after pituitary surgery, emerging techniques in neuromodulation, and the role of guidelines in promoting surgical quality. His popular writing and expert commentary has been featured by media outlets such as The Associated Press, The Independent, Natural History, Cell, Nature Publishing Group, BBC, and various blogs. In 2015, as guest editor, he led the creation of the first issue of the AMA Journal of Ethics devoted to neurosurgical ethics.
In 2014, Dr. Amadio was one of 15 young physicians to receive the American Medical Association Foundation’s Excellence in Medicine Award. He has been named “40 under 40” by the Atlanta Business Chronicle as well as “40 under 40 Healthcare Innovators” by MedTechBoston. He has been a featured keynote speaker at Genentech, Harvard Medical School, Princeton University, Georgia Tech, Mayo Clinic, TEDx, SXSW, and Exponential Medicine. He serves on the boards of several biotechnology companies and charitable foundations.